Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 51655-813

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 51655-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 813 54 Master Bottle Label Approval Rev A 06 21)

This is a description of a medicine called Ondansetron, which comes in the form of tablets. The tablets are to be stored at a temperature between 20°C and 25°C and protected from light. The text includes information about dosage, precautions, and the manufacturer's details. The tablets are repackaged by Northwind Pharmaceuticals and contain Ondansetron hydrochloride USP (dihydrate) which is equivalent to 8 mg of Ondansetron, a medication used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.